Skip to main content
. 2011 Sep;13(9):814–822. doi: 10.1111/j.1463-1326.2011.01412.x

Table 2.

Demographics and baseline characteristics by baseline OAD use in the pooled study and meta-analysis

Baseline number of OADs Type of OAD


Characteristic* Overall 0/1 OAD 2 OADs MET SU MET + SU
Pooled study
N 2154 1020 1134 185 792 1084
Age (years) 58.6 (10.1) 59.5 (10.6) 57.9 (9.5) 52.5 (9.9) 61.2 (10.1) 57.9 (9.5)
Sex (male; %) 55.6 56.0 55.3 51.9 56.4 54.9
Race (White; %) 88.3 90.7 85.8 71.9 95.6 86.1
Region (USA; %) 31.3 21.2 40.4 58.9 12.8 38.8
History of diabetes (years) 8.9 (6.2) 8.4 (6.0) 9.3 (6.4)§ 6.0 (4.1) 9.1 (6.2) 9.3 (6.4)
Baseline HbA1c (%) 8.77 (1.05) 8.87 (1.07) 8.68 (1.02) 9.08 (1.28) 8.84 (1.02) 8.67 (1.03)
Baseline FPG (mg/dl) 198.8 (52.3) 201.6 (51.6) 196.2 (52.7) 214.2 (60.2) 199.3 (49.4) 195.8 (52.9)
Baseline body weight (kg) 88.5 (17.7) 86.2 (17.4) 90.6 (17.7) 95.4 (19.8) 84.0 (16.3) 90.3 (17.5)
Meta-analysis
N 928 271 657 97 135 609
Age (years) 57.1 (9.5) 56.8 (9.7) 57.3 (9.4) 53.8 (9.2) 58.8 (9.4) 57.2 (9.3)
Sex (male; %) 58.6 62.4 57.1 57.7 63.0 56.3
Race (White; %) 88.2 88.6 88.1 90.0 88.9 88.5
Region (USA; %) 32.2 21.0 36.8 21.6 25.2 34.0
History of diabetes (years) 8.3 (5.74) 6.6 (4.5) 9.0 (6.0) 5.8 (3.5) 7.5 (4.7) 9.1 (6.1)
Baseline HbA1c (%) 8.69 (1.04) 8.70 (1.11) 8.68 (1.00) 8.72 (1.20) 8.71 (1.08) 8.67 (1.01)
Baseline FPG (mg/dl) 199.7 (51.1) 195.4 (48.9) 201.5 (51.9) 198.2 (54.6) 194.7 (46.9) 201.3 (52.3)
Baseline body weight (kg) 90.8 (17.9) 89.9 (17.4) 91.2 (18.1) 94.9 (18.9) 88.0 (16.4) 90.7 (17.7)

FPG, fasting plasma glucose; MET, metformin; OAD, oral antidiabetic drug; SU, sulfonylurea.

*

Data are mean (s.d.) unless otherwise specified.

n = 39 were not on any OAD; n = 71 were on ‘other’.

p < 0.05 for class comparison using an analysis of variance model with study and baseline OAD class as factors.

§

p < 0.05 versus 0/1 OAD group.

n = 36 were not on any OAD; n = 51 were on ‘other’.